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ABSTRACT
Objectives: Centered average on spectrum ratio by spectrophotometric technique has been done validated for acetaminophen (ACT) and ibuprofen 
(IBU) in mixture. The goal of this research is to analyze concurrent determination of ACT and IBU mixture in tablet, using pH 7.2 phosphate buffer and 
ethanol (91:9) as solvent mixture.
Methods: The spectrophotometric technique was made by addition of standard solution from IBU, and the absorption spectrum of each drug has 
been recorded, which is divided by corresponding concentration as a dividing factor; after that, the centered flat of ratio spectra of ACT and IBU 
concentrations was determined by calibration graphs with measuring at obtained maximum wavelengths 244 nm for ACT and 221 nm for IBU.
Results: The research results showed that linearly correlation acetominophen and IBU are 3.0–9.0 µg/mL and 5.0–13.0 µg/mL, respectively, and 
linearly regression equations are 1.5800X+0.4809 and 0.0991X+0.0205 with coefficient correlation are 0.9962 and 0.9990. Result of ACT and IBU 
in local tablet is 100.72±0.12% and 98.82±0.06% with the average of percentage recovery for ACT and IBU is 100.01% and 100.31%, and relative 
standard deviation value is 0.03% and 0.06% respectively.
Conclusion: It can be concluded that centered average on spectrum ratio spectrophotometric technique is a smooth, accelerated, correct, and rigid 
for the analysis of ACT and IBU in mixture.
Keywords: Acetaminophen, Ibuprofen, Spectrophotometric technique, Centered average on spectrum ratio.
INTRODUCTION
Acetaminophen (ACT) and ibuprofen (IBU) are the most common drug 
combination in analgesics and antipyretics preparation [1]. To achieve 
better quality control and safety, it is crucial in controlling the content 
of ACT and IBU in pharmaceutical tablets. ACT or 4-hydroxyacetanilide 
is a metabolite of phenacetin and considered as safe analgesic. ACT is 
sparingly soluble in water and used as a pain reliever in association of 
prostaglandin E2 reducer and lowers set point in hypothalamus [1].
IBU or 2-(4-isobutylphenyl)-propionic acid is nonsteroidal anti-
inflammatory drug used in rheumatoid arthritis and musculoskeletal 
disorder [2].
The chemical structure of ACT and IBU can be seen in Fig. 1a and b [2].
The presence of more than one active substances in drug can make a 
difficulty in assay analysis of each substance in pharmaceutical dosage 
form. The overlapped spectrum of each substance leads to this difficulty, 
and it is faced by applying a good simultaneous analysis method 
without prior separation and derivative steps [2]. Various methods 
have been published for the evaluation of ACT and IBU which are high-
performance liquid chromatography and derivative spectrophotometry 
method [3].
Conventional spectrophotometric technique cannot resolve the drugs in 
their mixtures with impurities or other drugs, so several manipulations 
were performed to enable resolution of binary and ternary mixtures. 
Binary mixtures can be determined using different order derivatives, 
methods, manipulating ratio spectrator dual wavelength, mean 
centered of ratio (MCR) spectra, and spectrophotometric technique 
using metal ion [4-9].
MCR spectra were developed by Afkhami and Bahram [9]. It is a 
smooth, accelerated, correct, and rigid technique used to determine the 
mixture of mefenamic acid and ACT, and mixture of three drugs, namely 
acetosal, ascorbic acid, and paracetamol. Other researches about ratio 
spectra which have been published are to determine binary mixture of 
drug [10-13].
In addition, spectrophotometric methods have potential application 
in pharmaceutical analysis as they provide easy and efficient 
results for binary and ternary mixtures compared to conventional 
methods [9,10-14,15].
The goal of this research is to apply centered flat of ratio spectra 
(CFRS) of spectrophotometric technique for the assay of ACT and IBU 
combination in pharmaceutical tablet using pH 7.2 phosphate buffer-
ethanol (91:9) as a solvent mixture and validation requirements such 
as accuracy and precision.
EXPERIMENT
Instruments
The spectrophotometric analysis of ACT and IBU by Shimadzu model 
1800 double beam UV-Visible spectrophotometer with spectral 
bandwidth of 1 nm and wavelength accuracy of 0.1 nm (at 656.1 nm D2) 
was used to measure the absorbance of all the solutions. Software used 
in the study are Spectra spontaneously access by UV-Probe system 
software and MATLAB version 9.0.
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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MATERIALS AND METHODS
Materials
Pharmaceutical grade of ACT was received from the Food and Drug 
Regulatory Agency of Indonesia (claimed purity of 100.31%); IBU 
supplied by Sigma-Aldrich (claimed purity of 99.90%); and ethanol 
absolute, sodium hydroxide, and potassium dihydrogen phosphate were 
purchased from Merck Ltd., Rudang, Medan, Indonesia. The product 
Indonesian local (contained 350 mg of ACT and 250 mg of IBU per tablet) 
was manufactured by PT Supra Ferbindo Farma, Tangerang, Indonesia.
Methods
Simultaneous determination of ACT and IBU mixture into a tablet 
using CFRS methods with a solvent mixture of phosphate buffer pH 7.2 
with ethanol (91:9) at the maximum wavelength of ACT was 243 nm 
(concentration of 6.6 µg/ml) and of IBU was 222 nm (concentration of 
8.0 µg/ml). In the CFRS process and methods using MATLAB software 
and measurement value is obtained centered flat value. ACT mixture 
and IBU performed at a maximum wavelength of ACT was 244 nm 
(concentration of 7.0 µg/mL) and of IBU was 221 nm (concentration 
of 9.0 µg/mL). In assay preparation  for tablet samples  the addition of 
standard solutions of IBU as ingredients in is used, to match the ACT 
content ratio in the measurement, so that when IBU as a divisor would 
made absorbs of the concentrations has used in terms of Lamber-beer 
law in the area of 0.2–0.6 [15].
Procedure of the experiment
Preparation of standard solutions
An accurately weighed standard of 50 mg ACT and 50 mg IBU powder 
was transferred to separate 100 mL volumetric flasks and dissolved by 
pH 7.2 phosphate buffer-ethanol solvent mixture. The volume was made 
up to mark with the same solvent mixture to achieve a concentration 
of 500 µg/mL of each ACT and IBU (standard solution I). Then, each 
standard solution I was taken 5 mL and transferred to separated 100 mL 
volumetric flasks, to achieve 25 µg/mL of each (standard solution II) [15].
Preparation of calibration solution
The ACT standard solution II was pipetted each 1.2 mL, 2 mL, 2.4 mL, 
3.2 mL, and 3.6 mL and transferred to 10 mL volumetric flasks to achieve 
concentration of 3 µg/mL, 5 µg/mL, 6 µg/mL, 8 µg/mL, and 9 µg/mL 
The IBU standard II was pipetted each 2 mL, 2.8 mL, 3.6 mL, 4.4 mL, 
and 5.2 mL and transferred to 10 mL volumetric flasks and dissolved 
by pH 7.2 phosphate buffer-ethanol solvent to achieve concentration 
of 5 µg/mL, 9 µg/mL, 11 µg/mL, and 13 µg/mL [2].
Spectral characteristics and wavelength selection
The absorption spectrum from ACT and 16 μg/mL standard solutions 
16 μg/mL IBU, each measured by ultraviolet spectrophotometry 
wavelength 200-320 nm and maximum absorption wavelength of ACT 
and IBU recorded, to be used as a measurement of absorption spectrum 
for the determination using the CFRS method.
Construction of spectrum ratio
Saved ACT spectra (3–9 µg/mL) were each divided by 9 µg/mL IBU 
to achieve first ratio spectra mediated by UV Probe, and IBU spectra 
(5–13 µg/mL) were divided by 8 µg/mL ACT to achieve first ratio 
spectra mediated by UV Probe. The first ratio spectra of ACT and first 
ratio spectra of IBU spectra were then made for mean centered using 
MATLAB software (Mathworks) [9].
Construction of calibration graphs for CFRS
The centered flat or amplitude values of the first ratio of ACT and IBU 
ratios at the maximum wavelength obtained were calculated and plotted 
at 244 nm and 221 nm with ACT and IBU concentrations, respectively, 
to obtain the regression line equation.
Validation test
The CFRS spectrophotometric method was validated by investigating 
the following parameters [16,17].
Linearity
Standard solution of ACT and IBU for spectrum absorption was made 
and measured at the selected wavelength point (244 nm for ACT and 
221 nm for IBU). The amplitude values of both active substances were 
determined using the regression equation for each component at its 
own selected wavelength.





x = Concentration (μg/mL)
b = Constant.
Recovery test
Accuracy was determined using standard addition method by preparing 
analyte with three specific ranges of 80%, 100%, and 120%, with three 
repetitions each. Every specific range contained 70% analyte and 30% 
standard and then analyzed by the same procedure above. In standard 
addition method (added the purify active substances), a number of 
samples analyzed plus analytes with the necessary concentration of the 
analyte concentration expected, mixed, and analyzed. Differences from 
the results were compared with the theoretical concentration [16]. In 
that method, the levels of substances were obtained as the ratio of the 








%R = Percentage of recovery
Ca = Concentration after addition
CC = Theoretical concentration before addition
Cb = Concentration of the standard substances added.
Relative standard deviation (RSD) test
RSD obtained from the regression equation was calculated in the 






RSD = Relative standard deviation
SD = Standard deviation
X  = Average data.
Limit of detection (LOD) and limit of quantification (LOQ) test
According to the absorbance at analysis wavelength, LOD and LOQ are 





















SD = Standard deviation
Slope = a (y = ax+b)
Calibration graphs of each ACT and IBU were obtained by plotting the 
mean center (MC) values versus corresponding concentrations, and the 
regression equations of ACT and IBU were obtained.
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Preparation of ACT and IBU mixture by self-made
An accurately weighed standard of 50 mg ACT and 50 mg IBU powder 
was transferred to separate 100 mL volumetric flasks and dissolved 
by pH 7.2 phosphate buffer-ethanol solvent mixture. Pippeted 20 mL 
of ACT solution and 14 mL of IBU solution to 50 mL volumetric flask 
and dissolved by pH 7.2 phosphate buffer-ethanol solvent mixture 
until line mark, shaken until homogeneous. Subsequently, the filtrate 
was accommodated, pipetted 1.75 mL, and transferred to other 50 mL 
flask. Standard solution of IBU (25 µg/mL) was pipetted 10 mL and 
transferred in a 50 mL flask and dissolved by pH 7.2 phosphate buffer-
ethanol solvent which contains 1.75 mL filtrate. The mixture was made 
up to mark with pH 7.2 phosphate buffer-ethanol solvent mixture to 
obtain a solution which contained the concentration of 7.0 µg/mL of 
ACT and 9.0 µg/mL of IBU. The absorption of solution was recorded 
in the wavelength range 200–400 nm. Then, the same procedure of 
construction of ratio spectra and centered average on spectrum ratio 
was used [15].
Determination of ACT and IBU mixture in pharmaceutical tablet
Twenty tablets were weighed and powdered in a mortar. Furthermore, 
a number of weighed powder equivalent to 10 mg of ACT and IBU 
was calculated based on the equality to ACT (weighing powders were 
repeated 6 times). Subsequently transferred in a 50 mL volumemetric 
flask, and dissolved by solvent of pH 7.2 phosphate buffer-ethanol 
(homogenized with sonicator for 15 min), and then were made up with 
pH 7.2 phosphate buffer-ethanol solvent  until the line mark, shaken 
until homogeneous. The solution was then filtered, approximately 
10 mL of the first filtrate discarded. Subsequently, the filtrate was 
accommodated, pipetted 1.75 mL, and transferred in an other 50 mL 
flask. Standard solution of IBU (25 µg/mL) was pipetted 10 mL, 
transferred in a 50 mL flask, and dissolved by pH 7.2 phosphate buffer-
ethanol solvent which contains 1.75 mL filtrate. The mixture was made 
up to mark with pH 7.2 phosphate buffer-ethanol solvent mixture to 
obtain a solution which contained the concentration of 7.0 µg/mL of 
ACT and 9.0 µg/mL of IBU. The absorption of solution was recorded 
in the wavelength range 200–400 nm. To obtain the MC values of each 
ACT and IBU in tablet, the same procedure above (construction of ratio 
spectra and centered on ratio spectra) was used [9,15].
RESULTS AND DISCUSSION
The creation of CFRS from ACT and IBU based on mathematical 
equations exemplified by Afkhami and Bahram that MCR methods 
can be used for the simultaneous determination of binary and ternary 
mixtures without the separation. That to explain the MC expression, the 















The MC of the above vector was be done by subtracting from the above 



























































It is assumed that the mixture contains three compounds X, Y, and Z. If 
there is no interaction between the compounds, then the mathematical 
equation is as follows:
Am = αxCX+αyCY+αzCZ (1)
Where Am is a vector of mixed absorbance, αx, αy, and αz are molar 
absorptivity vectors of X, Y, and Z, and Cx, Cy, and Cz are concentrations 
of X, Y, and Z. If the equation (1) divided by αZ is the spectrum of standard 
solution Z, then the first ratio spectrum is obtained by equation (2) with 














If equation (2) is made MC, since the MC constant value is 0, then the 
























By dividing equation (3) with MC (αY/αZ), corresponding to the 
centered average on spectrum ratio of standard solutions Y and Z, the 
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Equation (5) shows that there is a linear relationship between the 
number of MC (D) and the X concentration in the solution. Then, the 
calibration curve can be made by plotting (D) against the X concentration 
from the X standard solution in the mixture [9].
Optimization of absorption spectrum conditions for CFRS method
Molecular absorption methods in UV spectrophotometry have been 
widely used for the determination of drug levels in pharmaceutical 
preparations, especially in developing simpler, faster, and more reliable 
analytical methods [2]. This technique can be used for pharmaceutical 
analysis to have an inherent constraint since most of the active drug 
mixture has a spectrum adjacent to the UV area and overlap making it 
difficult to determine the simultaneous level of the mixture [3].
The maximum absorption of ACT and IBU spectrum is overlapped, and 
the result of the overlap can be seen in Fig. 2.
Based on Fig. 2, it can be seen that the results of maximum absorption 
spectrum were done at wavelength range 200–400 nm that maximum 
wavelength of ACT in pH 7.2 phosphate buffer-ethanol (91:9) was 
244 nm and IBU was 222 nm [15]. Construction of Fig. 2 was made by 
combining a spectrum of ACT (6.6 µg/mL) and IBU (8.0 µg/mL).
It showed that most of the IBU absorption spectrum was overlapped 
by ACT absorption spectrum so that direct spectrophotometric method 
was unable to be used to determine ACT and IBU mixture. Differ from 
direct spectrophotometric method, CFRS method was able to determine 
ACT and IBU mixture.
Construction of ACT and IBU absorption spectra at various 
concentrations
The stability of the absorption of ACT and IBU in pH 7.2 phosphate 
buffer and ethanol (91:9) mixed solvent has been made by 
measurement of the absorption of the standard solution with varying 
concentrations. The absorption spectrum of various concentrations 
can be seen in Figs. 3 and 4.
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Based on Figs. 3 and 4, it can be seen that ACT and IBU spectra in 
pH 7.2 phosphate buffer-ethanol (91:9) solvent mixture showed that 
concentration did not change the spectra so that solvent mixture usage 
was stable against for ACT and IBU solution.
That means measurements in accordance with The fourth edition of 
the Indonesian Pharmacopoeia that the use of solvents is permitted in 
spectrophotometric method if the solvent only changes the maximum 
wavelength of the component of the drug, if it is not more than 3% of 
the wavelength stated in the literature [2].
Construction spectrum of ratio from CFRS
The CFRS method constructed by reference to previous research on 
the developed MCR method depends on the centralized average of the 
resulting spectrum ratio [9], which eliminates the derivative steps, and 
therefore, the signal-to-noise ratio is increased [9]. To optimize the 
developed CFRS technique, several different parameters are tested. 
Among other wavelengths taken will have a large influence on the MC 
ratio spectrum obtained, different wavelength ranges are then tested 
and the best results were obtained using a wavelength range from 
200 to 300 nm and 200 to 280 nm, respectively, for ACT and IBU. The 
influence of the divisor concentration on the selectivity of the method 
has been tested.
Different concentrations of each ACT and IBU were tested. It was found 
that the divisor concentration had no significant effect on the specificity 
of the determination of ACT and IBU, and therefore, the normalized 
spectra of each ACT and IBU were used as a divisor.
As shown in Fig. 2, the absorption spectra of ACT and IBU appear to 
overlap. In this case, the absorption spectra of ACT standard solutions 
of different concentrations are recorded in the wavelength range of 
200–300 nm and divided by the normalized IBU spectrum, and the 
ratio spectrum obtained is the MC. Similarly, for the determination 
of IBU, the absorption spectra of standard IBU solutions of different 
concentrations were recorded in the wavelength range of 200–280 nm 
and divided by the normal spectrum of ACT and the average centered 
ratio spectrum (Fig. 5). The concentration of IBU is determined by 
measuring the amplitude at 244.0 nm according to the maximum 
wavelength as shown in the same figure.
In CFRS spectrophotometric technique, it was begun by constructing 
ratio spectra and divisor concentration determination. Divisor 
concentration was chosen from the concentration range for Lambert-
Beer law compliance.
The tablet sample that will be determined is the content of ACT and 
IBU has a ratio of 7: 4 while the compilation of the determination 
of ACT concentration spectrophotometry is 8.0 μg/mL and 4.57 
μg/mL ibuprofen, because based on the concentration of Ibuprufen 
measurement below the minimum limit of absorbance below 0 2, 
so that it is added additively using a standard solution so that the 
measured concentration is in the absorbance area according to the 
requirements of the Lambert Beer law that is absorbance in the area of 
Fig. 1: The chemical structure of structure acetaminophen (a) and 
structure of ibuprofen (b) [2]
Fig. 2: Overlapping absorption spectrum of acetaminophen and 
ibuprofen
Fig. 3: Absorption spectra of acetaminophen at various 
concentrations
Fig. 4: Absorption spectra of ibuprofen at various concentrations
a b
Fig. 6: Ratio absorption spectrum of acetaminophen with 
9.0 µg/mL ibuprofen as divisor
Fig. 5: Means centered on the spectrum ratio of the ibuprofen
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0.2-0.6.Besides that the concentration of IBU was 4.43 μg/mL to be in 
the area absorbance 0.4343.
Concentration of ACT used in this experiment was 8.0 µg/mL and IBU 
9.0 µg/mL. Ratio spectra were done to diminish the effect of other 
substance and must not contain zero absorption value [8]. The results 
can be seen in the Figs. 6 and 7.
Result of MC value for ACT and IBU
Result of the maximum wavelength of ACT and IBU and their MC values 
can be seen in Figs. 5 and 8.
ACT and IBU calibration curve
Calibration curve in CFRS method is constructed by concentrations 
versus amplitude (MC results) graph. Regression equation that obtained 
using CFRS method for ACT is as follows:
MCACT = 1.58C+0.4809
r = 0.9963




C = The concentration in µg/mL
MC = Mean centered value,
r = Correlation coefficient.
It is mean that the calibration curve of CFRS has a linear regression 
because the value of correlation coefficient which is >0.97 shows that 
there is a linear correlation between concentration and amplitude.
Results of validation test
The average of percentage recovery for both ACT and IBU was 
100.01% and 100.31%, respectively. These values fulfilled the accuracy 
requirement such as 98–102% [2].
The RSD of both ACT and IBU was 0.03% and 0.06%, respectively, and 
fulfilled precision requirement such as <2% [13,14]. LOD and LOQ for 
ACT were 0.843 µg/mL and 2.811 µg/mL, respectively, while for IBU 
were 0.636 µg/mL and 2.119 µg/mL, respectively. Based on the results 
above, it can be stated that the CFRS method has good accuracy and 
precision, besides that from the above results it can be seen that all 
measurements carried out are in the 0.2–0.6 absorption area which 
means that the sample measurements are also above the detection limit 
and the quantitation limit [17].
Therefore, it can be concluded that the CFRS method has met the 
method validation requirements, in determining the levels of ACT 
and IBU and also in accordance with publications from various other 
researchers using the Mean Centered Ratio spectra method that uses 
various mixtures of drugs with different solvents have validity with 
parameters, accuracy, precision, linearity, LOD and LOQ [9,10-13,14].
Determination of ACT and IBU in sample
Preparation samples solution of made by self-made and brand 
tablet was conduct done by standard addition method because the 
concentration of IBU during measurement is too small so it needs to 
use the standard addition method so that its IBU can be measured fulfill 
Lambert Beer’s law.
Preparation of sample solution from brand tablets by dissolving the 
sample in solvent ethanol- pH 7.2 buffer phosphate and measuring 
the absorption spectrum at a wavelength of 200–400 nm to obtain 
the sample absorption spectrum. Then, the spectrum was divided by 
a predetermined divisor to obtain the ratio spectrum of each drug. 
Then, the ratio spectra of the ACT and IBU are filtered by the MATLAB 
Table 1: MC values of ACT and IBU on tablet








MC: Mean center, ACT: Acetaminophen, IBU: Ibuprofen
Table 2: Theoretical and practice concentrations of ACT








1. 11.6377 7.0613 7.0247
2. 11.6365 7.0605 7.0247
3. 11.5864 7.0288 7.0087
4. 11.5735 7.0206 6.9995
5. 11.5719 7.0196 6.9970
6. 11.6253 7.0534 7.0176
MC: Mean center, ACT: Acetaminophen, IBU: Ibuprofen
Table 3: Theoretical and practice concentrations of IBU








1. 0.4138 3.9692 4.0141
2. 0.4142 3.9733 4.0141
3. 0.4129 3.9601 4.0051
4. 0.4130 3.9612 3.9996
5. 0.4126 3.9571 3.9983
6. 0.4135 3.9662 4.0100
MC: Mean center, IBU: Ibuprofen
Fig. 7: Ratio absorption spectrum of ibuprofen with 8.0 µg/mL 
acetaminophen as divisor
Fig. 8: Means centered on the spectrum ratio of the 
acetaminophen
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application to obtain the MC value, and then, calculated the rate 
obtained using the regression equation.
In determining the sample rate, it is taken the amplitude value at the 
maximum peak that has been directed and then inserted into the 
regression equation that has been obtained previously. The data MC 
value of ACT and IBU on tablet is summarized in Table 1, and the results 
of theoretical and practice concentrations of ACT and IBU are given in 
Tables 2 and 3. The result of statiscally determining ACT and IBU in 
brand tablets is given in Table 4.
Based on Tables 1-4, it can be seen that the results of measurements 
of a self-made and local product were not significant by statistical test 
and meet the requirements contained in Indonesian Pharmacopeia 
5th edition (2014). It is mean that the assay methods of CFRS can be used 
for simultaneous determination of ACT and IBU in tablet dosage form.
CONCLUSION
The centered flat of ratio spectra is a swift, exact, and fixed quantitative 
spectrophotometric technique and has been implemented in the 
determination of ACT and IBU in laboratory working and pharmaceutical 
tablet. The levels of ACT and IBU in tablet were 100.72±0.12% and 
98.82±0.06%, respectively, and fulfilled accuracy and precision 
requirements with average percentage recovery of 100.01% and 
100.31%, also RSD values of 0.03% and 0.06%, respectively.
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2. IBU 199.74±0.28 197.64±0.12
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